Výsledky vyhledávání - "Olga Valkovsky"

P-192: Patient reported outcome & family reported outcome and the most correlated clinical measures over one year of follow-Up

Autor: Kareem Midlig, Barbara Silverman, Regina Draliuk, Elena Mishchenko, Olga Valkovsky, Shoshan Perek, Amir Warwar, Evelyne Shabad, Iveta Mintsman, Meir Preis, Mouna Ballan-Haj

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 22:S140-S141

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::13be4aee8572add1950364ac048ca156
https://doi.org/10.1016/s2152-2650(22)00522-5

Zobrazit plný text záznamu

Pneumococcal Vaccination (PCV13) Prior to Initiation of Immunosuppressive Therapy in Patients with Hematological Malignancies Is Associated with Decrease Morbidity and Decrease Hospitalizations

Autor: Shuras Viky, Noga Salem, Alla Shnaider, Iveta Mintsman, Antonio Kotler, Regina Draliuk, Elena Mishchenko, Evelyne Shabad, Meir Preis, Rotem Benami, Olga Valkovsky, Mouna Ballan Haj

Publikováno v: Blood. 132:5919-5919

Introduction: Pneumococcus is a common bacterium that can cause serious infections, such as pneumonia, meningitis or blood stream infection in patients receiving immunosuppressive therapy. Infection by pneumococcus bacteria can be life-threatening le

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6462f83956839d13500050ea18687932
https://doi.org/10.1182/blood-2018-99-118483

Zobrazit plný text záznamu

Primary Nk/T-Cell lymphoma of the Larynx

Autor: Nechama Uri, Yaakov Schindler, Olga Valkovsky, Miriam Quitt, Geva Barzilai

Publikováno v: Ear, Nose & Throat Journal. 91:206-207

Laryngeal extranodal non-Hodgkin lymphoma is uncommon, accounting for less than 1% of all laryngeal neoplasms; the B-cell phenotype is predominant. Lymphomas outside the nasal cavity are rare and highly aggressive. We present a case of primary natura

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf230ff95558433602cb7c0be1d21f9c
https://doi.org/10.1177/014556131209100510

Zobrazit plný text záznamu

Delayed Onset Adverse Effects Associated with Rituximab Treatment in Patients with Non-Hodgkin's Lymphoma – A Single Center Experience

Autor: Evelyne Shabad, Miriam Quitt, Salim Habib Alla, Olga Valkovsky, Eitan Mangoubi

Publikováno v: Blood. 120:4888-4888

Abstract 4888 Introduction. Rituximab (RTX), a chimeric anti-CD20 monoclonal antibody, has now become a cornerstone in the treatment of many CD20 positive B cell lymphomas. RTX induces a rapid depletion of normal CD20 expressing B-cells in the periph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca9e2da141597f0490b176fbd72590a4
https://doi.org/10.1182/blood.v120.21.4888.4888

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání